Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 1/20 | 0.54 |
| ▸ | GNB1 | P62873 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | SMAD3 | P84022 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4056456 | 0.85 | FTO (0.62) | GNG2GNB1MAPTMEN1KMT2A | |
| SCHEMBL876011 | 0.84 | MAPT (0.49) | GNG2GNB1MAPTMEN1KMT2A | |
| SCHEMBL546598 | 0.80 | FTO (0.48) | GNG2GNB1MAPTMEN1KMT2A | |
| SCHEMBL11500382 | 0.79 | MAPT (0.51) | GNG2GNB1MAPTMEN1KMT2A | |
| SCHEMBL10913508 | 0.79 | FTO (0.42) | GNG2GNB1MAPTMEN1KMT2A | |
| SCHEMBL19211134 | 0.79 | DHFR (0.47) | GNG2GNB1MAPTMEN1KMT2A | |
| SCHEMBL8741821 | 0.77 | ALDH1A1 (0.49) | GNG2GNB1MAPTMEN1KMT2A | |
| SCHEMBL10615586 | 0.77 | FTO (0.48) | GNG2GNB1MAPTMEN1KMT2A | |
| SCHEMBL10583381 | 0.77 | FTO (0.45) | GNG2GNB1MAPTMEN1KMT2A | |
| SCHEMBL1209657 | 0.76 | FTO (0.43) | GNG2GNB1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080193955-A1 | Kit and Method for the Detection of Anti-Hepatitis C Virus (Hcv) Antibodies | CUI PENG | 2008-08-14 | — | — | US | claimed |
| CN-111558349-B | Double-chamber microcapsule with self-warning function and preparation method thereof | 江南大学 | 2021-11-02 | — | — | CN | disclosed |
| CN-111558349-A | Double-chamber microcapsule with self-warning function and preparation method thereof | 江南大学 | 2020-08-21 | — | — | CN | disclosed |
| US-7658937-B2 | Anthraquinones and process for the preparation and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2010-02-09 | — | — | US | disclosed |
| US-20090029348-A1 | Kit for Detecting the Antibody of HCV and Its Preparing Method | FAPON BIOTECH INC. (CN) | 2009-01-29 | — | — | US | disclosed |
| US-20080193955-A1 | Kit and Method for the Detection of Anti-Hepatitis C Virus (Hcv) Antibodies | CUI PENG | 2008-08-14 | — | — | US | disclosed |
| EP-1845378-A1 | A KIT FOR DETECTING THE ANTIBODY OF HCV AND ITS PREPARING METHOD | Cui, Peng (CN) | 2007-10-17 | — | — | EP | disclosed |
| EP-1745000-A2 | NOVEL ANTHRAQUINONES AND PROCESS FOR THE PREPARATION AND METHOD OF USE THEREOF | Michigan State University (US) | 2007-01-24 | — | — | EP | disclosed |
| US-20050267307-A1 | Novel anthraquinones and process for the preparation and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2005-12-01 | — | — | US | disclosed |
| WO-2005113478-A2 | NOVEL ANTHRAQUINONES AND PROCESS FOR THE PREPARATION AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050267307-A1 | Novel anthraquinones and process for the preparation and method of use thereof | PAH, APEH, SDHA | GNG2 1636/4885GNB1 1551/4885MAPT 3904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.